Takeda And Enterome To Jointly Mine The Microbiome

In a deal that further expands its credentials, French company Enterome has inked an alliance with Japan's Takeda to conduct research and develop novel therapeutics aimed at microbiome targets thought to play crucial roles in gastrointestinal disorders.

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia